ABSTRACT CONTROLLED RELEASE DOSAGE FORMS OF 5-AMINOSALICYLIC ACID AND PROCESS THEREOF Accordingly, the invention provides controlled release minitablets of 5-ASA with high drug load and less net weight for easier administration. In another aspect of the present invention, the process of preparation of 5-ASA or its...

ABSTRACT SOLID PHARMACEUTICAL DOSAGE FORMS OF VITAMIN K AND PROCESS OF PREPARATION THEREOF The present disclosure relates to a dry process for preparing a solid pharmaceutical dosage form of vitamin K1 comprising: a) blending vitamin K1 with a first diluent under a first set of pre-determined conditions to obtain ...

ABSTRACT FORMULATIONS COMPRISING CHLORPROMAZINE HYDROOCHLORIDE, AND PROCESS OF PREPARATION THEREOF The present disclosure relates to a process for preparing a pharmaceutical formulation, said process comprises: i) blending chlorpromazine hydrochloride and microcrystalline cellulose under a first set of pre-det...

ABSTRACT CAPSULE DOSAGE FORMS OF TRIAMTERENE, AND PROCESS OF PREPARATION THEREOF The present disclosure provides for a capsule dosage form of triamterene, the dosage form comprising: a) triamterene having a weight percentage in a range of 25 – 45% with respect to the total ingredients in the capsule dosage form; b...

ABSTRACT NONGRANULATED MESALAMINE FORMULATIONS AND PROCESS OF PREPARATION THEREOF The present disclosure discloses a composition suitable for direct compression into tablets without prior granulation procedures comprising: a) mesalamine or its prodrug or derivatives thereof and b) at least one pharmaceuti...

ABSTRACT MATRIX MESALAMINE EXTENDED RELEASE MINITABLETS AND ITS PROCESS THEREOF Compositions for development of matrix type extended release mesalamine minitablets without use of any modified release coating, comprising a) mesalamine or its prodrug or derivatives thereof having a weight percentage in a range of 65...